Cannabis and acute psychosis

Area of Science:

• Psychiatry
• Neuroscience
• Addiction Medicine

Background:

• Cannabis use is prevalent globally, with ongoing debate regarding its potential to induce or exacerbate psychosis.
• The concept of 'cannabis psychosis' as a distinct diagnostic entity remains controversial in clinical and research settings.

Purpose of the Study:

• To investigate whether psychotic patients with positive cannabis screening exhibit unique psychopathological features or demographic profiles compared to drug-free controls.
• To evaluate the validity of 'cannabis psychosis' as a distinct diagnostic entity.

Main Methods:

• Utilized the Present State Examination to assess psychopathology in 23 psychotic patients with confirmed cannabis use (urinary screening).
• Compared these patients with 46 matched drug-free individuals, analyzing diagnoses, illness onset, admission rates, ethnicity, and socio-economic status.

Main Results:

• No significant differences were found in psychopathology, DSM-III diagnoses, illness onset, first admission rates, ethnicity, or socio-economic class between cannabis-positive psychotic patients and controls.
• The primary distinguishing factor was the history of substance use.

Conclusions:

• Psychosis associated with cannabis use does not present with a characteristic psychopathology or mode of onset.
• The findings provide limited evidence to support 'cannabis psychosis' as a valid, independent diagnostic category.
• Psychosis in the context of cannabis use is not limited to specific ethnic or socio-demographic groups.